Skip to main content

Cincinnati Genome Institute to Use Genedata's Software for High-Throughput Screening

NEW YORK (GenomeWeb News) – The University of Cincinnati will use Genedata’s data analysis software for high-throughput screening in its pharmaceutical studies program, the company said today.
 
Under the collaborative agreement, the Drug Discovery Center at the university's Genome Research Institute will use Genedata's Screener software for high-throughput and high-content screening research projects.
 
The company said that the software includes assay data management and analysis tools that are independent of tools, technology, volume, or location.
 
The DDC is developing molecular probes for use in pharmaceutical and biotechnology applications.
 
Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.